| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.8 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.0065 | 0.8 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |